Skip to main content
Vinati Organics Ltd. logo

Vinati Organics Ltd. — Investor Relations & Filings

Ticker · VINATIORGA ISIN · INE410B01037 LEI · 254900Q2IRNXURG92U10 BSE.NS Manufacturing
Filings indexed 701 across all filing types
Latest filing 2026-02-02 Report Publication Anno…
Country IN India
Listing BSE.NS VINATIORGA

About Vinati Organics Ltd.

https://vinatiorganics.com

Vinati Organics Ltd. is a leading manufacturer of specialty chemicals and organic intermediates. The company is the world's largest producer of 2-Acrylamido 2-Methylpropane Sulfonic Acid (ATBS) and Isobutyl Benzene (IBB). Its product portfolio includes various specialty monomers and aromatics such as Butyl Phenols and HP-MTBE. These chemicals serve diverse applications in water treatment, enhanced oil recovery, pharmaceuticals, personal care, and polymer manufacturing. The company focuses on high-purity chemical production through integrated manufacturing processes and advanced research and development. Vinati Organics maintains a significant global presence, exporting its products to major markets across North America, Europe, and Asia, while emphasizing operational efficiency and sustainable chemical synthesis.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of unaudited standalone and consolidated financial results for the third quarter and nine months ended December 31, 2025. It references compliance with SEBI Listing Regulations and mentions that the financial results were published in newspapers and uploaded on the company's website. The document itself is short (3183 characters) and primarily serves as a notification of the publication of the financial results rather than containing the full financial report or detailed financial data. According to the 'MENU VS MEAL' rule, such a document is an announcement about the report's publication, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2026-02-02 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 90% confidence The document is a regulatory disclosure under SEBI Listing Regulations notifying the outcome of a Board meeting and submitting unaudited financial results (standalone and consolidated) for the third quarter and nine months ended December 31, 2025, including full interim financial statements and limited review report. This goes beyond a simple earnings highlights release and contains comprehensive quarterly financial data, fitting the definition of an Interim/Quarterly Report (IR). 9M 2026
2026-01-31 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 93% confidence The document is an outcome of the Board meeting disclosing the unaudited financial results (standalone and consolidated) for the quarter and nine‐month period ended December 31, 2025, filed under SEBI Listing Regulations. It includes full line‐by‐line financial statements and the Limited Review Report by the auditors, which constitutes a comprehensive interim report rather than just a brief earnings release or an annual report. Therefore it should be classified as an Interim / Quarterly Report. 9M 2026
2026-01-31 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-23 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice of an upcoming Board Meeting scheduled to consider and approve unaudited financial results for a quarter and nine months period. It is addressed to stock exchanges and references compliance with SEBI Listing Regulations. The document does not contain actual financial data or results but is an announcement of the meeting where such results will be reviewed. The document length is short (1826 characters), and it serves as an intimation rather than the financial report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and compliance notice rather than an Interim Report (IR) or Earnings Release (ER).
2026-01-23 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding an additional investment in a wholly owned subsidiary company. It details the subscription to additional equity shares in the subsidiary, including the cost, percentage of shareholding, and business details of the subsidiary. There are no financial statements or comprehensive financial performance data presented. The document is an announcement of a capital investment transaction, specifically a subscription to shares in a subsidiary, which fits the category of Capital/Financing Update (CAP). The document length is about 4865 characters, which is sufficient to provide substantive information about the transaction but does not constitute a full financial report or earnings release.
2026-01-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.